{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:38:47Z","timestamp":1762033127729,"version":"build-2065373602"},"reference-count":94,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Perinatal brain injury can be induced by a number of different damaging  events occurring during or shortly after birth, including neonatal asphyxia, neonatal hypoxia-ischemia and stroke-induced focal ischemia. Typical manifestations of these conditions are the presence of glutamate excitoxicity, neuroinflammation and oxidative stress, the combination of which can potentially result in apoptotic-necrotic cell death, generation of brain lesions and long-lasting functional impairment. In spite of the high incidence of perinatal brain injury, the number of clinical interventions available for the treatment of the affected newborn babies is extremely limited. Hence, there is a dramatic need to develop new effective therapies aimed to prevent acute brain damage and enhance the endogenous mechanisms of long-term brain repair. The endocannabinoid system is an endogenous neuromodulatory system involved in the control of multiple central and peripheral functions. An early responder to neuronal injury, the endocannabinoid system has been described as an endogenous neuroprotective system that once activated can prevent glutamate excitotoxicity, intracellular calcium accumulation, activation of cell death pathways, microglia activation, neurovascular reactivity and infiltration of circulating leukocytes across the blood-brain barrier. The modulation of the endocannabinoid system has proven to be an effective neuroprotective strategy to prevent and reduce neonatal brain injury in different animal models and species. Also, the beneficial role of the endocannabinoid system on the control of the endogenous repairing responses (neurogenesis and white matter restoration) to neonatal brain injury has been described in independent studies. This review addresses the particular effects of several drugs that modulate the activity of the endocannabinoid system on the progression of different manifestations of perinatal brain injury during both the acute and chronic recovery phases using rodent and non-rodent animal models, and will provide a complete description of the known mechanisms that mediate such effects.<\/jats:p>","DOI":"10.3390\/brainsci3031043","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T10:56:10Z","timestamp":1373453770000},"page":"1043-1059","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury"],"prefix":"10.3390","volume":"3","author":[{"given":"David","family":"Fern\u00e1ndez-L\u00f3pez","sequence":"first","affiliation":[{"name":"Neonatal Brain Disorders Center, Department of Neurology, University of California San Francisco, San Francisco, 94158 CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Lizasoain","sequence":"additional","affiliation":[{"name":"Neurovascular Research Unit, Department of Pharmacology, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moro","sequence":"additional","affiliation":[{"name":"Neurovascular Research Unit, Department of Pharmacology, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez-Orgado","sequence":"additional","affiliation":[{"name":"Department of Neonatology-Pediatrics, University Hospital Puerta de Hierro Majadahonda,  Madrid 28222, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMra041996","article-title":"Neonatal brain injury","volume":"351","author":"Ferriero","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2000-9293","article-title":"Hypoxic-ischemic encephalopathy","volume":"17","author":"Vannucci","year":"2000","journal-title":"Am. J. Perinatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A","article-title":"Perinatal brain injury: From pathogenesis to neuroprotection","volume":"7","author":"Volpe","year":"2001","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1523\/JNEUROSCI.13-04-01441.1993","article-title":"Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention","volume":"13","author":"Oka","year":"1993","journal-title":"J. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","article-title":"Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury","volume":"21","author":"Back","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pneurobio.2009.01.003","article-title":"Periventricular white matter damage in the hypoxic neonatal brain: Role of microglial cells","volume":"87","author":"Kaur","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1542\/peds.2011-1148","article-title":"Symptomatic neonatal arterial ischemic stroke: The international pediatric stroke study","volume":"128","author":"Kirton","year":"2011","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2003.10.001","article-title":"Selective vulnerability in the developing central nervous system","volume":"30","author":"McQuillen","year":"2004","journal-title":"Pediatr. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"506320","DOI":"10.1155\/2012\/506320","article-title":"Molecular mechanisms of neonatal brain injury","volume":"2012","author":"Thornton","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.STR.0000047101.87575.3C","article-title":"Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain","volume":"34","author":"Manabat","year":"2003","journal-title":"Stroke"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainresrev.2005.07.003","article-title":"Apoptosis in perinatal hypoxic-ischemic brain injury: How important is it and should it be inhibited?","volume":"50","author":"Northington","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.2006.04269.x","article-title":"Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: A role for gender","volume":"100","author":"Renolleau","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1073858408316003","article-title":"Astrocyte responses after neonatal ischemia: The yin and the yang","volume":"14","author":"Villapol","year":"2008","journal-title":"Neuroscientist"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2004.04.003","article-title":"Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse","volume":"16","author":"Plane","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1203\/01.PDR.0000179381.86809.02","article-title":"Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat","volume":"58","author":"Ong","year":"2005","journal-title":"Pediatr. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.21068","article-title":"Sustained neocortical neurogenesis after neonatal hypoxic\/ischemic injury","volume":"61","author":"Yang","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/glia.20013","article-title":"New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents","volume":"46","author":"Zaidi","year":"2004","journal-title":"Glia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.21359","article-title":"Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury","volume":"63","author":"Segovia","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clp.2009.07.013","article-title":"Neuroprotection in the newborn infant","volume":"36","author":"Gonzalez","year":"2009","journal-title":"Clin. Perinatol."},{"key":"ref_20","first-page":"494","article-title":"Hypothermia: A neuroprotective therapy for neonatal hypoxic ischemic encephalopathy","volume":"12","author":"Marks","year":"2010","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.siny.2010.02.003","article-title":"Hypothermia: A systematic review and meta-analysis of clinical trials","volume":"15","author":"Shah","year":"2010","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2011.08.004","article-title":"Hypothermia and other treatment options for neonatal encephalopathy: An executive summary of the Eunice Kennedy Shriver NICHD workshop","volume":"159","author":"Higgins","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1469-8749.1995.tb12035.x","article-title":"Prevention by magnesium of excitotoxic neuronal death in the developing brain: An animal model for clinical intervention studies","volume":"37","author":"Marret","year":"1995","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"c2005","DOI":"10.1136\/bmj.c2005","article-title":"Xenon shows promise to prevent brain injury from lack of oxygen in newborns","volume":"340","author":"Mayor","year":"2010","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nbd.2005.05.019","article-title":"Topiramate prevents excitotoxic damage in the newborn rodent brain","volume":"20","author":"Sfaello","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1933719107305864","article-title":"Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage","volume":"14","author":"Spandou","year":"2007","journal-title":"Reprod. Sci."},{"key":"ref_27","first-page":"405","article-title":"Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats","volume":"33","author":"Palmer","year":"1993","journal-title":"Pediatr. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/adc.2005.086652","article-title":"Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia","volume":"91","author":"Benders","year":"2006","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jnr.20261","article-title":"N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain","volume":"78","author":"Paintlia","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jnr.21890","article-title":"Minocycline: A neuroprotective agent for hypoxic-ischemic brain injury in the neonate?","volume":"87","author":"Buller","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2003.11.002","article-title":"Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats","volume":"153","author":"Kumral","year":"2004","journal-title":"Behav. Brain Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/01.STR.0000173406.04891.8c","article-title":"Neonatal hypoxia\/ischemia is associated with decreased inflammatory mediators after erythropoietin administration","volume":"36","author":"Sun","year":"2005","journal-title":"Stroke"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000105473","article-title":"Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke","volume":"29","author":"Gonzalez","year":"2007","journal-title":"Dev. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12264-011-1008-6","article-title":"Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury","volume":"27","author":"Alvarez","year":"2011","journal-title":"Neurosci. Bull."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1073858406296407","article-title":"The endocannabinoid system and neurogenesis in health and disease","volume":"13","author":"Aguado","year":"2007","journal-title":"Neuroscientist"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2174\/138161208785740117","article-title":"Mechanisms of control of neuron survival by the endocannabinoid system","volume":"14","author":"Aguado","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20557","article-title":"Predictors of outcome in perinatal arterial stroke: A population-based study","volume":"58","author":"Lee","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(04)00679-9","article-title":"Stroke in newborn infants","volume":"3","author":"Nelson","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pediatrneurol.2008.09.018","article-title":"Advances in perinatal ischemic stroke","volume":"40","author":"Kirton","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/STROKEAHA.106.479311","article-title":"Maternal and infant characteristics associated with perinatal arterial stroke in the preterm infant","volume":"38","author":"Benders","year":"2007","journal-title":"Stroke"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/spen.2000.20074","article-title":"Stroke in children: Recognition, treatment, and future directions","volume":"7","author":"deVeber","year":"2000","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/STROKEAHA.108.533976","article-title":"Late emergence of cognitive deficits after unilateral neonatal stroke","volume":"40","author":"Westmacott","year":"2009","journal-title":"Stroke"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/AOG.0b013e3181a66d57","article-title":"Neonatal outcomes after elective cesarean delivery","volume":"113","author":"Kamath","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1055\/s-0029-1216346","article-title":"Neurobiology and systems physiology of the endocannabinoid system","volume":"42","author":"Wegener","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/febs.12212","article-title":"Transport of endocannabinoids across the plasma membrane and within the cell","volume":"280","author":"Fowler","year":"2013","journal-title":"FEBS J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09540260902782760","article-title":"Basic neuroanatomy and neuropharmacology of cannabinoids","volume":"21","author":"Breivogel","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: Physiology and pharmacology","volume":"40","author":"Bilbao","year":"2005","journal-title":"Alcohol Alcohol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1073858406296716","article-title":"Endocannabinoids and synaptic function in the CNS","volume":"13","author":"Hashimotodani","year":"2007","journal-title":"Neuroscientist"},{"key":"ref_49","first-page":"12","article-title":"Cannabis and cannabinoids: Pharmacology and rationale for clinical use","volume":"6","author":"Pertwee","year":"1999","journal-title":"Forsch Komplementarmed"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1874467210801030273","article-title":"Functional selectivity in cannabinoid signaling","volume":"1","author":"Varga","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-011-8210-5","article-title":"Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease","volume":"51","author":"Basu","year":"2011","journal-title":"Immunol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: An overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/mol.105.016428","article-title":"Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity","volume":"69","author":"Kim","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1385\/MN:26:2-3:317","article-title":"Acute neuronal injury, excitotoxicity, and the endocannabinoid system","volume":"26","author":"Veldhuis","year":"2002","journal-title":"Mol. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0163-7258(02)00256-5","article-title":"Cannabinoids and cell fate","volume":"95","author":"Guzman","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s001090000177","article-title":"Control of the cell survival\/death decision by cannabinoids","volume":"78","author":"Guzman","year":"2001","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1096\/fj.06-6164fje","article-title":"Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation","volume":"20","author":"Palazuelos","year":"2006","journal-title":"FASEB J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1096\/fj.05-3995fje","article-title":"The endocannabinoid system drives neural progenitor proliferation","volume":"19","author":"Aguado","year":"2005","journal-title":"FASEB J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.3101-05.2006","article-title":"The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells","volume":"26","author":"Aguado","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M700678200","article-title":"The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis","volume":"282","author":"Aguado","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/NMM:7:1-2:037","article-title":"Cannabinoid receptors and their role in neuroprotection","volume":"7","year":"2005","journal-title":"Neuromolecular Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.09-141275","article-title":"Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment","volume":"24","author":"Murikinati","year":"2010","journal-title":"FASEB J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neuropharm.2005.01.005","article-title":"Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores","volume":"48","author":"Zhuang","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature02913","article-title":"Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids","volume":"431","author":"Bacci","year":"2004","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1471-4159.2001.00465.x","article-title":"Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells","volume":"78","author":"Esposito","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/glia.20108","article-title":"Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes","volume":"49","author":"Sheng","year":"2005","journal-title":"Glia"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","article-title":"Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats","volume":"60","author":"Nunez","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jneumeth.2005.01.005","article-title":"Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy","volume":"145","author":"Casanova","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1","article-title":"Rat model of perinatal hypoxic-ischemic brain damage","volume":"55","author":"Vannucci","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1203\/PDR.0b013e318123fbb8","article-title":"The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats","volume":"62","author":"Pazos","year":"2007","journal-title":"Pediatr. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1074\/jbc.M111.291294","article-title":"CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling","volume":"287","author":"Palazuelos","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/brain\/aws194","article-title":"Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity","volume":"135","author":"Butti","year":"2012","journal-title":"Brain"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1161\/STROKEAHA.110.599357","article-title":"The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia","volume":"41","author":"Pradillo","year":"2010","journal-title":"Stroke"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1460-9568.2007.05782.x","article-title":"Cannabinoids modulate olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2","volume":"26","author":"Gomez","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2011.01414.x","article-title":"Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K\/Akt and the mammalian target of rapamycin (mTOR) pathways","volume":"163","author":"Gomez","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/glia.21061","article-title":"The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation","volume":"58","author":"Gomez","year":"2010","journal-title":"Glia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1203\/PDR.0b013e3182276b11","article-title":"Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs","volume":"70","author":"Lafuente","year":"2011","journal-title":"Pediatr. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11064-011-0594-z","article-title":"The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia","volume":"37","author":"Alvarez","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0168-0102(98)00096-0","article-title":"Neonatal reversible focal cerebral ischemia: A new model","volume":"32","author":"Derugin","year":"1998","journal-title":"Neurosci. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuroscience.2012.01.008","article-title":"Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke","volume":"207","author":"Faustino","year":"2012","journal-title":"Neuroscience"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1471-4159.2006.04162.x","article-title":"Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke","volume":"100","author":"Denker","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/STROKEAHA.111.631044","article-title":"Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage\/microglial activation concomitant to neuroprotection","volume":"43","author":"Zarruk","year":"2012","journal-title":"Stroke"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/3\/3\/1043\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:47:50Z","timestamp":1760219270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/3\/3\/1043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":94,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,9]]}},"alternative-id":["brainsci3031043"],"URL":"https:\/\/doi.org\/10.3390\/brainsci3031043","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}